A Three-part Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-2640 in Healthy Participants (Part I) and Participants With Type 1 Diabetes Mellitus (Parts II and III) (MK-2640-001)
Clinical trial NCT02269735 · COMPLETED
Trial details
- NCT number
- NCT02269735
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-26
- Primary completion
- 2016-07-29
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.